Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Predictive Oncology Inc.
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
August 13, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
August 07, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
July 26, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
July 25, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
June 11, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
June 04, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
May 29, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
May 10, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine
April 30, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
March 28, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology to Participate in Upcoming Investor Conferences
February 21, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology to Participate in Upcoming San Francisco Conferences
January 02, 2024
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
November 08, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
November 07, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
August 03, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
July 18, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
June 27, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board
June 20, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
RTX
USPH
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention
May 23, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update
May 15, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023
May 08, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors
May 02, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Announces Reverse Stock Split
April 20, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Predictive Oncology Adjourns Special Meeting of Stockholders
April 17, 2023
From
Predictive Oncology Inc.
Via
GlobeNewswire
Tickers
POAI
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.